|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 208.00 GBX | 0.00% |
|
-1.42% | -7.96% |
| 06-16 | EDX Medical and Spire Healthcare ink memorandum of understanding | AN |
| 06-16 | EDX Medical, Spire Healthcare to Collaborate on New Diagnostic Services | MT |
| Capitalization | 837M 1.13B 979M 921M 1.54B 97.44B 1.73B 10.82B 4.18B 44.57B 4.23B 4.14B 163B | P/E ratio 2025 * |
22.1x | P/E ratio 2026 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 2.03B 2.74B 2.38B 2.24B 3.75B 237B 4.2B 26.29B 10.16B 108B 10.28B 10.06B 396B | EV / Sales 2025 * |
1.27x | EV / Sales 2026 * | 1.17x |
| Free-Float |
65.28% | Yield 2025 * |
1.22% | Yield 2026 * | 1.85% |
More valuation ratios
* Estimated data
More news
Last Transcript: Spire Healthcare Group plc
More recommendations
More press releases
More news
| 1 day | -0.24% | ||
| 1 week | -1.42% | ||
| Current month | +7.44% | ||
| 1 month | +4.73% | ||
| 3 months | +16.46% | ||
| 6 months | -8.37% | ||
| Current year | -7.96% |
| 1 week | 205 |  | 213.5 |
| 1 month | 188.8 | | 214 |
| Current year | 168.2 | | 239.19 |
| 1 year | 168.2 | | 263 |
| 3 years | 168.2 | | 270.5 |
| 5 years | 72.6 | | 270.5 |
| 10 years | 51.1 | | 411 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justinian Ash
CEO | Chief Executive Officer | 60 | 2017-10-29 |
Harbant Samra
DFI | Director of Finance/CFO | - | 2024-05-08 |
Lisa Grant
CTO | Chief Tech/Sci/R&D Officer | - | 2023-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Justinian Ash
BRD | Director/Board Member | 60 | 2017-10-29 |
C. van der Merwe
BRD | Director/Board Member | 61 | 2018-05-23 |
Jenny Kay
BRD | Director/Board Member | - | 2019-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -1.42% | -12.05% | -3.03% | 1.13B | ||
| -0.66% | -2.89% | +5.30% | -48.87% | 15.77B | ||
| -0.58% | -0.58% | +9.60% | +9.08% | 14.33B | ||
| +1.02% | +0.84% | +41.06% | +123.06% | 12.01B | ||
| -1.04% | +0.22% | +11.69% | +87.33% | 11.67B | ||
| -1.41% | -1.41% | -22.22% | -13.22% | 10.39B | ||
| +1.75% | +4.98% | +29.46% | +120.81% | 8.78B | ||
| +0.41% | -7.92% | -43.26% | - | 7.35B | ||
| -0.33% | -2.55% | +51.12% | +233.63% | 6.66B | ||
| -0.81% | -1.78% | -24.50% | -48.43% | 5.5B | ||
| Average | -0.19% | -1.17% | +4.62% | +51.15% | 9.36B | |
| Weighted average by Cap. | -0.23% | -0.91% | +8.04% | +47.15% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.6B 2.15B 1.87B 1.76B 2.95B 186B 3.3B 20.67B 7.99B 85.17B 8.08B 7.91B 312B | 1.69B 2.27B 1.97B 1.86B 3.11B 196B 3.49B 21.8B 8.43B 89.85B 8.53B 8.35B 329B |
| Net income | 38.44M 51.78M 44.96M 42.31M 70.86M 4.48B 79.41M 497M 192M 2.05B 194M 190M 7.49B | 60.04M 80.89M 70.23M 66.09M 111M 6.99B 124M 776M 300M 3.2B 304M 297M 11.7B |
| Net Debt | 1.2B 1.61B 1.4B 1.32B 2.21B 139B 2.47B 15.47B 5.98B 63.75B 6.05B 5.92B 233B | 1.14B 1.54B 1.34B 1.26B 2.11B 133B 2.36B 14.77B 5.71B 60.86B 5.78B 5.65B 223B |
More financial data
* Estimated data
Employees
15,703
Calendar
07-30
- Q2 2025 Earnings Call
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-18 | 208.00 p | 0.00% | 286,757 |
| 25-06-17 | 208.00 p | -0.95% | 445,559 |
| 25-06-16 | 210.00 p | +0.72% | 294,813 |
| 25-06-13 | 208.50 p | -0.48% | 837,791 |
| 25-06-12 | 209.50 p | -0.71% | 587,151 |
Delayed Quote London S.E., June 18, 2025 at 11:35 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.080GBP
Average target price
2.840GBP
Spread / Average Target
+36.54%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SPI Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition